ÖZER, Ö. And YORULMAZ, G. 2020. Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic. Jcpsp-Journal Of The College Of Physicians And Surgeons Pakistan , vol.30, no.2 , 110-111.

ÖZER, Ö., & YORULMAZ, G., (2020). Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic. Jcpsp-Journal Of The College Of Physicians And Surgeons Pakistan , vol.30, no.2, 110-111.

ÖZER, ÖZGE, And GÖKNUR YORULMAZ. "Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic," Jcpsp-Journal Of The College Of Physicians And Surgeons Pakistan , vol.30, no.2, 110-111, 2020

ÖZER, ÖZGE And YORULMAZ, GÖKNUR. "Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic." Jcpsp-Journal Of The College Of Physicians And Surgeons Pakistan , vol.30, no.2, pp.110-111, 2020

ÖZER, Ö. And YORULMAZ, G. (2020) . "Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic." Jcpsp-Journal Of The College Of Physicians And Surgeons Pakistan , vol.30, no.2, pp.110-111.

@article{article, author={ÖZGE ÖZER And author={GÖKNUR YORULMAZ}, title={Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic}, journal={Jcpsp-Journal Of The College Of Physicians And Surgeons Pakistan}, year=2020, pages={110-111} }